How well are the effects of liraglutide on cardiovascular events for patients without diabetes documented?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18769921
Cited by: 0

Abstract

Liraglutide appears to offer some reductions in cardiovascular events in non-diabetic patients, though significant uncertainties remain regarding its impact on stroke and cardiovascular mortality.

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins Blood Pressure and Hypertension Studies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 February 2026
Language
EN